YWCA Toronto honours and celebrates the remarkable achievements of six change-makers who challenge systemic discrimination, ...

It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is ...

Indivior PLC today announced the appointment of Patrick Barry as Chief Commercial Officer, effective June 2. In this role, Barry will lead the company's commercial growth strategy, execution, and ...

The global contract research organization (CRO) services market is expected to witness a growth rate of 9% in the next five ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced ...

The Malvern location of Fujirebio Diagnostics Inc.’s played key role in the clinical development of the first FDA-approved ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

The health AI "super app" wants to add more nutrition data to its platform with this buy, its second acquisition of the yar.